Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.
−$893M
FY2024 · ▲ $227M vs FY2023
| Fiscal year | Year end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount, by fiscal year |
|---|---|---|
| FY2024 | Sep 28, 2024 | −$893,000,000 |
| FY2023 | Sep 30, 2023 | −$1,120,000,000 |
| FY2022 | Sep 24, 2022 | −$1,871,000,000 |
| FY2021 | Sep 25, 2021 | −$2,137,000,000 |
| FY2020 | Sep 26, 2020 | −$930,000,000 |
| FY2019 | Sep 28, 2019 | −$639,000,000 |
| FY2018 | Sep 29, 2018 | −$675,000,000 |
| FY2017 | Sep 30, 2017 | $0 |
| Period | Length | Value | Last reported | Filings |
|---|---|---|---|---|
| Oct 1, 2023 – Sep 28, 2024 | Year | −$893,000,000 | Nov 1, 2024 | 1 |
| Sep 25, 2022 – Sep 30, 2023 | Year | −$1,120,000,000 | Nov 1, 2024 | 2 |
| Sep 26, 2021 – Sep 24, 2022 | Year | −$1,871,000,000 | Nov 1, 2024 | 3 |
| Sep 27, 2020 – Sep 25, 2021 | Year | −$2,137,000,000 | Nov 3, 2023 | 3 |
| Sep 29, 2019 – Sep 26, 2020 | Year | −$930,000,000 | Oct 28, 2022 | 3 |
| Sep 30, 2018 – Sep 28, 2019 | Year | −$639,000,000 | Oct 29, 2021 | 3 |
| Oct 1, 2017 – Sep 29, 2018 | Year | −$675,000,000 | Oct 30, 2020 | 2 |
| Sep 25, 2016 – Sep 30, 2017 | Year | $0 | Oct 31, 2019 | 1 |